Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - OPERATING EXPENSES
Operating Expenses AXSM - Axsome Therapeutics, Inc.
633 M
LAST VALUE
69.10%
2 YEAR CAGR
56.65%
5 YEAR CAGR
60.77%
10 YEAR CAGR